zeatin has been researched along with Encephalopathy, Toxic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SG; Choi, SJ; Chun, JY; Heo, HJ; Jeong, CH; Kim, YJ; Lee, J; Shin, DH | 1 |
1 other study(ies) available for zeatin and Encephalopathy, Toxic
Article | Year |
---|---|
Zeatin prevents amyloid beta-induced neurotoxicity and scopolamine-induced cognitive deficits.
Topics: Alzheimer Disease; Amnesia; Amyloid beta-Peptides; Animals; Antioxidants; Behavior, Animal; Brain; Cholinergic Antagonists; Cognition Disorders; Learning; Lipid Peroxidation; Memory; Mice; Mice, Inbred ICR; Morus; Neurotoxicity Syndromes; PC12 Cells; Phytotherapy; Plant Extracts; Plant Leaves; Protective Agents; Rats; Reactive Oxygen Species; Scopolamine; Zeatin | 2009 |